Article
WT1 gene mutations impact post-transplant relapse in myelodysplastic syndrome with excess blasts 2 patients.
Annals of hematology - 1 Aug 2024
Guo Wenwen, Zhang Haixiao, Wang Mingyang, Zheng Yawei, Cao Yigeng, Zhang Xiaoyu, Zhai Weihua, Zhang Rongli, Yang Donglin, Wei Jialin, He Yi, Ma Qiaoling, Xia Yonghui, Pang Aiming, Feng Sizhou, Han Mingzhe, Jiang Erlie
Abstract excerpt
Wilms tumor 1 (WT1) gene mutations are infrequent in myelodysplastic syndrome (MDS), but MDS with WT1 mutations (WT1mut) is considered high risk for acute myeloid leukemia (AML) transformation. The influence of WT1 mutations in patients with MDS after allogeneic hematopoietic stem cell transplantation (allo-HSCT) is unclear. We performed a retrospective analysis of 136 MDS with excess blasts 2 (MDS-EB2) patients...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
